Evidence map›Paper›PMID 41838349›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2026

Challenging esophageal surgery: risk factors, outcomes, and a comparative single-center analysis.

Leonardo Duranti, Luca Tavecchio, Luigi Rolli, Piergiorgio Solli

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Leonardo DurantiThoracic Surgery Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via Venezian1, 20133, Milan, Italy. leonardo.duranti@istitutotumori.mi.it.ORCID http://orcid.org/0000-0001-6529-5151
Luca TavecchioThoracic Surgery Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via Venezian1, 20133, Milan, Italy.
Luigi RolliThoracic Surgery Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via Venezian1, 20133, Milan, Italy.
Piergiorgio SolliThoracic Surgery Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via Venezian1, 20133, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionEsophageal cancer ranks as the eighth most common cancer among human populations and stands as the sixth leading cause of cancer-related deaths. Effective treatment of esophageal tumors necessitates a comprehensive, multidisciplinary approach encompassing surgery, chemotherapy, and radiotherapy.

methodIn our series of 203 esophagectomies conducted at our institution, we identified 28 procedures (13.7%) categorized as "challenging esophagectomies" based on specific predefined criteria outlined in the text. These criteria encompassed factors such as medical comorbidities, local tumor extension, and involvement of lymph nodes. The remaining 175 patients comprised the group of "standard esophagectomies".

resultsWe compared our study group with the standard group. There was no statistical difference between the two groups regarding overall 5 year survival and disease-free survival. In the "challenging esophagectomies" group, our overall 5 year survival rate was 34.2%, and the disease-free survival rate was 56, 4%. In the "standard" group, our overall 5 year survival rate was 48, 6%, and the disease-free survival rate was 58, 6%. Specifically, in the "challenging esophagectomies" group, the post-operative mortality rate stood at 8%, with major complications occurring in 33% of cases, in "standard group" the post-operative mortality rate stood at 2%, with major complications occurring in 23% of cases.

conclusionDespite the challenges associated with difficult esophagectomies, they play a pivotal role not only as salvage surgeries but also as a crucial component within the integrated multimodal treatment strategy. Patient selection emerges as a critical factor influencing outcomes. For this purpose, we propose a classification system of criteria and scores to define the level of complexity in this surgery.

Indexed as

AdenocarcinomaEsophageal NeoplasmsEsophagectomyAgedDisease-Free SurvivalFemaleHumansMaleMiddle AgedPostoperative ComplicationsRetrospective StudiesRisk FactorsSurvival RateTreatment OutcomeEsophageal cancerEsophageal surgeryEsophagectomy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.